China NMPA Product Recall - Testosterone Assay Kit (Chemiluminescent Microparticle Immunoassay) 2nd Generation Testosterone Reagent Kit

On July 6, 2021, the National Medical Products Administration (NMPA) publicly reported a voluntary recall initiated by Abbott GmbH, Germany, concerning its 2nd Generation Testosterone Reagent Kit (Chemiluminescent Microparticle Immunoassay). This recall, affecting a product registered under Certificate No. 20162404132, was brought to the NMPA's attention by Abbott Trading (Shanghai) Co., Ltd. The critical issue identified was a significant mismatch between the barcode displayed on specific models and batches of the testosterone assay kit and its most current, approved project documentation. Such a discrepancy could lead to incorrect product identification or improper operational procedures, potentially impacting diagnostic accuracy and patient safety. Operating under the regulatory framework of the NMPA, Abbott GmbH proactively chose to remove the affected kits from circulation. The required action involves a comprehensive voluntary recall to mitigate any risks associated with this documentation error. Detailed information, including the specific recall level, affected product models, precise specifications, and relevant batch numbers, is available in the "Medical Device Recall Event Report Form" provided as an attachment to the official notice, ensuring transparency and guiding necessary corrective actions.